Former President Trump's allies are pre-screening the

New Post Public Reply Private Reply Replies (2) Message Board
dw
371
Former President Trump's allies are pre-screening the ideologies of thousands of potential foot soldiers, as part of an unprecedented operation to centralize and expand his power at every level of the U.S. government if he wins in 2024, officials involved in the effort tell Axios.

Why it matters: Hundreds of people are spending tens of millions of dollars to install a pre-vetted, pro-Trump army of up to 54,000 loyalists across government to rip off the restraints imposed on the previous 46 presidents.

The screening for ready-to-serve loyalists has already begun, driven in part by artificial intelligence from tech giant Oracle, contracted for the project.
Social media histories are already being plumbed.
What's happening: When Trump took office in 2017, he included many conventional Republicans in his Cabinet and key positions. Those officials often curtailed his behavior and power.

Trump himself spends little time plotting governing plans. But he is well aware of a highly coordinated campaign to be ready to jam government offices with loyalists willing to stretch traditional boundaries.
If Trump were to win, thousands of Trump-first loyalists would be ready for legal, judicial, defense, regulatory and domestic policy jobs. His inner circle plans to purge anyone viewed as hostile to the hard-edged, authoritarian-sounding plans he calls "Agenda 47."

The people leading these efforts aren't figures like Rudy Giuliani. They're smart, experienced people, many with very unconventional and elastic views of presidential power and traditional rule of law.
Behind the scenes: The government-in-waiting is being orchestrated by the Heritage Foundation's well-funded Project 2025, which already has published a 920-page policy book from 400+ contributors. Think of it as a transition team set in motion years in advance.

Heritage president Kevin Roberts tells us his apparatus is "orders of magnitude" bigger than anything ever assembled for a party out of power.

The policy series, "Mandate for Leadership," dates back to the 1980s. But Paul Dans, director of Project 2025, told us: "Never before has the entire movement ... banded together to construct a comprehensive plan to deconstruct the out-of-touch and weaponized administrative state."
Project 2025 gets muscle from 80 partners, including Turning Point USA, led by MAGA star Charlie Kirk; the Center for Renewing America, headed by former Trump budget director Russ Vought; and American Moment, focused on young believers for junior positions.

A separate group of former Trump officials — the America First Policy Institute, led by Brooke Rollins — has a Pathway to 2025 laying groundwork for what it calls "the next America First administration."
Trump insiders relish rebuilding the team with purists. But the truth is, they have no choice: Many more-traditional Republicans quit the first administration in frustration or were fired by tweet. And some former advisers are talking to prosecutors or are charged with crimes.

The Trump campaign tells us no outside group speaks for him: "The campaign's Agenda47 is the only official comprehensive and detailed look at what President Trump will do when he returns to the White House. ... While the campaign is appreciative of any effort to provide suggestions about a second term, the campaign is not collaborating with them."

Questions for Heritage Foundation's Project 2025 applicants. Screenshot via Project 2025 website
How it works: The most elaborate part of the pre-transition machine is a résumé-collection project that drills down more on political philosophy than on experience, education or other credentials.

Applicants are asked to "name one person, past or present, who has most influenced the development of your political philosophy" — and to do the same with a book.
Another query: "Name one living public policy figure whom you greatly admire and why."
Details: Heritage's "Presidential Personnel Database" already has 4,000+ entries, we're told.

We're told immense, intense attention will be given to the social-media histories of anyone being considered for top jobs. Those queasy about testing the limits of Trump's power will get flagged and rejected.
The massive headhunting quest aims to recruit 20,000 people to serve in the next administration, as a down payment on 4,000 presidential appointments + potential replacements for as many as 50,000 federal workers who are "policy-adjacent," as Trumpers put it.
Reality check: Technically, this apparatus will be inherited by any Republican nominee — Heritage officials tell us they've briefed the campaigns of Trump, Ron DeSantis and Nikki Haley.

But this is undeniably a Trump-driven operation. The biggest tell: Johnny McEntee — one of Trump's closest White House aides, and his most fervent internal loyalty enforcer — is a senior adviser to Project 2025.
One of the most powerful architects is Stephen Miller, a top West Wing adviser for the Trump administration. Miller is charting an even harder line on legal and immigration policy than last time. While he maps a White House return, he's president of America First Legal, which vows to fight "lawless executive actions and the Radical Left."

Between the lines: Trump doesn't hide his intentions. It's important to tune out the theatrical language that drives social media and cable TV, and focus intently on the directional guidance of his second term.

He's telling us exactly what he intends to do — like it or loathe it. And this time, he'll have prefabbed institutional muscle to turn pugilistic words into policies and action from the get-go.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 120

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 99

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 710

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Onodrim Raises $300M to Propel EU Defence Future

Updated Category News Views 20

Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...

Continue Reading
Wuliangye Aims for Global Branding Boost at Panda Event

Updated Category News Views 179

Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 312

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
KT&G Launches Heated Tobacco in Kazakhstan's Market

Updated Category News Views 43

KT&G Lights Up Kazakhstan In a bold move, KT&G is laying down the gauntlet in Kazakhstan's tobacco market, introducing its cutting-edge heated tobacco gizmo and a handful of sleek FAIIM sticks. Launching this October, these aren't just any devices—they're the FLEX locals have been waiting for, rebranded from South Korea's lil AIBLE and AIIM but made to fit right in with...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 474

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
AI Shopping Surge: WeFetch.ai's Bold Rebrand Move

Updated Category News Views 134

Shifting Gears: GreenCore Solutions Becomes WeFetch.ai Here's a shift you don't see every day. GreenCore Solutions has morphed into WeFetch.ai, aiming to sail the ever-growing AI shopping seas. This isn't just a new nameplate; it's a declaration of intent to dive headfirst into the market dynamics driven by artificial intelligence. It's bold and, frankly, pretty timely....

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 172

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Traditions Bancorp Declares New Cash Dividend for Investors

Updated Category News Views 76

Traditions Bancorp Declares Quarterly Cash Dividend On a recent date, the Board of Directors of Traditions Bancorp (OTC: TRBK), the parent company of Traditions Bank, announced a quarterly cash dividend of eight cents per common share. This dividend reflects the company's strong commitment to returning value to its shareholders and will be disbursed shortly. The payment...

Continue Reading
LONGi BC Tech Paves the Way for Solar Leadership in Europe

Updated Category News Views 334

LONGi's Impact on Europe's Solar Industry LONGi, recognized as a leader in solar technology, has made remarkable strides in reshaping the renewable energy scene in Europe. With an impressive 10GW of back contact (BC) modules deployed, the continent is rapidly becoming a hotbed for high-efficiency solar solutions. This accomplishment underlines the company's crucial...

Continue Reading
PACS Group Investors: Important Actions to Take Now

Updated Category News Views 152

Important Deadline for PACS Group Investors Investors in PACS Group, Inc. are advised to take note of an important lead plaintiff application deadline related to recent securities class action lawsuits. If you have incurred losses exceeding $100,000 in the company's stock, you may be eligible to participate in these legal proceedings. Class Action Lawsuit Details The...

Continue Reading
Exploring Market Sentiment Around Morningstar Inc and Its Trends

Updated Category News Views 207

Understanding Morningstar Inc's Market Position Morningstar Inc (NYSE:MORN) has recently shown a notable decline in its short interest, with a decrease of 9.22% reported. Currently, there are approximately 655 thousand shares sold short, constituting about 2.56% of the total shares available for trading. This information is pivotal for investors since it reflects the...

Continue Reading
Julie Springer Expands Legal Services with Mediation Practice

Updated Category News Views 363

Julie Springer's New Ventures in Mediation In the dynamic legal scene of Austin, seasoned attorney Julie A. Springer is making waves by broadening her practice to include mediation and arbitration services. This thoughtful transition reflects her long-time dedication to effectively settling business disputes, educational conflicts, and employment issues. Professional...

Continue Reading